Dexcom News

Dexcom G5® Mobile Continuous Glucose Monitoring System Receives CE Mark

First and only mobile-connected CGM with no confirmatory finger sticks needed for treatment decisions* for adults and children as young as 2 years of age. The Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System has received CE Mark (Conformite Europeenne) and will be available in several European countries in the coming weeks.

FDA Approves Dexcom G5® Mobile Continuous Glucose Monitoring System

First and Only Fully Mobile CGM System Allows Adults and Children as young as 2 years old to Conveniently and Discreetly Monitor and Share Glucose Levels

Dexcom and Nick Jonas Raise Their Voices for Diabetes Awareness

“When I was first diagnosed, I was scared that I would no longer be able to do what I love but I made a commitment to take control of my diabetes and not let it slow me down", said Nick Jonas. "The Dexcom CGM is an amazing step forward in the battle against diabetes and gives me the tools and confidence I need to feel in control so I can continue to follow my dreams.”

Dexcom Introduces Apps That Enable the First Ever Continuous Glucose Monitoring (CGM) on the Apple Watch™

Now People With Diabetes and Caregivers Have Access to Life-Saving Glucose Data in a Convenient and Discreet Manner Right from their Wrist.

FDA Approves Dexcom G4 Platinum Continuous Glucose Monitoring System with Share

Now people with diabetes as young as 2 years of age can automatically and securely share real-time CGM data from their Dexcom receiver to a caregiver's mobile app

Kevin Sayer Assumes Role of President and Chief Executive Officer; Terry Gregg Transitions to Role of Executive Chairman

Dexcom announced that Kevin Sayer, currently the Company's President and Chief Operating Officer, has assumed the role of President and Chief Executive Officer to succeed Terry Gregg, who is transitioning to the role of Executive Chairman after more than seven years of service as DexCom’s President and Chief Executive Officer.

FDA Approves Dexcom Software with Artificial Pancreas Algorithm

The U.S. Food and Drug Administration (FDA) has approved new software for the Dexcom G4® PLATINUM CGM. The new Software 505 features the same advanced algorithm as used in artificial pancreas research around the world. The software will impact the performance of the Dexcom G4 PLATINUM, already considered the most accurate CGM system on the market today. The software will be made available free of charge to adult patients using the Dexcom G4 PLATINUM.

FDA approves Dexcom SHARE™, the first remote mobile communications device used for Continuous Glucose Monitoring (CGM)

Dexcom SHARE, an accessory to the Dexcom G4® PLATINUM Continuous Glucose Monitoring System, uses a secure wireless connection to transmit the glucose levels of a person with diabetes to the smartphones of up to five designated recipients, or “followers.” These followers can remotely monitor a patient’s glucose information and receive alert notifications from almost anywhere via their Apple® iPhone® or iPod® touch. With Dexcom SHARE, parents and personal caregivers can monitor a child’s or loved one’s glucose data from a remote location, giving them peace of mind and reassurance when they are apart.

Dexcom Announces Data Integration Relationship with Asante Solutions, Makers of the Snap™ Insulin Pump

Asante Solutions, Inc., manufacturer of the Asante Snap Insulin Pump, and Dexcom announced today their intention to enable the Dexcom mobile app platform, which is currently under development, to integrate and display insulin data from the Asante Snap Insulin Pump.

Dexcom's Forthcoming Mobile App Platform to Integrate Data from Insulet's OmniPod System

Insulet Corporation and Dexcom announced today their intention to enable DexCom's mobile App platform, which is currently under development, to integrate data from Insulet's OmniPod System.